An Observational Study to Assess Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)

Launched by ABBVIE · May 31, 2024

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • During a routine visit, investigator will decide whether artificial tears are the appropriate treatment for potential participants with dry eyes and will then consider enrollment into this study.
• * Participant with at least one sign of dry eye:
• • Three consecutive tear break-up time (TBUT) tests \<= 10 seconds in at least one eye at Screening Visit OR;
• • Grade 1 to 4 (modified National Eye Institute \[NEI\] Grid, score range = 0 to 5) staining in at least 1 area of the cornea (5 areas examined) or conjunctiva (6 areas examined) that is related to dry eye in at least 1 eye at both at Screening Visit.
• • Use of digital devices of 8 hours or more per day.
• * Adult participants who answer yes to the following questions:
• • Do you use digital devices at least 8 hours per day? Yes or No
• • Are your eyes dry, irritated while using a digital screen like a computer or smartphone? Yes or No
• Exclusion Criteria:
• • Use of artificial tears in the last 24 hours.
• • Current use of more than 4 drops of artificial tears per day in each eye.
• • Use of dry eye treatment other than artificial tears.
• • Are currently on ocular medications.

Trial Officials